Association of mobiluncus curtisii with recurrence of bacterial vaginosis

Sexually Transmitted Diseases

Volumn 35, Issue 6, 2008, Pages 611-613

  Meltzer, Michelle C ^a   Desmond, Renee A ^a   Schwebke, Jane R ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; METRONIDAZOLE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; DISEASE ASSOCIATION; DRUG WITHDRAWAL; HIGH RISK POPULATION; HUMAN; IN VITRO STUDY; MOBILUNCUS CURTISII; MOBILUNCUS MULIERIS; PREVALENCE; RECURRENT DISEASE; TREATMENT FAILURE; VAGINA DISCHARGE; VAGINA FLORA; VAGINITIS; BACTERIAL INFECTION; CLASSIFICATION; DRUG COMBINATION; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOBILUNCUS; POLYMERASE CHAIN REACTION; VAGINA;

ACTINOMYCETALES INFECTIONS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; METRONIDAZOLE; MOBILUNCUS; POLYMERASE CHAIN REACTION; RECURRENCE; VAGINA; VAGINOSIS, BACTERIAL;

EID: 48049124571     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318167b105     Document Type: Article

References (13)

1. Fleury FJ. Adult vaginitis. Clin Obstet Gynecol 1981; 24:407-438.
2. Amsel R, Totten PA, Spiegel CA, et al. Non-specific vaginitis: Diagnostic and microbial and epidemiological associations. Am J Med 1983; 74:14-22.
3. Gravett M, Nelson H, DeRouen T, et al. Independent associations of bacterial vaginosis and Chlamydia trachomatis. infection with adverse pregnancy outcome. JAMA 1986; 256:1899-1903.
4. Hillier S. The vaginal microbial ecosystem and resistance to HIV. AIDS 1998; 14:17-21.
5. Joesoef MR, Schmid GP, Hillier SL. Bacterial vaginosis: Review of treatment options and potential clinical indications for therapy. Clin Infect Dis 1999; 28:S57-S65.
6. Ferris M, Masztal A, Aldridge KE, et al. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 2004; 4:5.
7. Swidsinski A, Mendling W, Loening-Baucke V, et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol 2005; 106:1013- 1023.
8. Schwebke JR, Desmond RA. A randomized trial of metronidazole duration plus or minus azithromycin for treatment of symptomatic bacterial vaginosis. Clin Infect Dis 2007; 44:213-219.
9. Holst E, Wathne B, Hovelius B, et al. Bacterial vaginosis: Microbiological and clinical findings. Eur J Clin Microbiol 1987; 6: 536-541.
10. Roberts MC, Hillier SL, Schoenknecht FC, et al. Comparison of gram stain, DNA probe and culture for the identification of species of Mobiluncus in female genital specimens. J Infect Dis 1985; 152:74-77.
11. Spiegel CA. Susceptibility of Mobiluncus species to 23 antimicobial agents and 15 other compounds. Antimicrob Agents Chemother 1987; 31:249-252.
12. Tiveljung A, Forsum U, Monstein H. Classification of the genus Mobiluncus based on comparative partial 16S rRNA gene analysis. Int J Syst Bacteriol 1996; 46:332-336.
13. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991; 29:297-301.